Renal Anhydramnios Fetal Therapy | MicrobiomeTrials← Back to trialsNCT03101891
Renal Anhydramnios Fetal Therapy
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2018-12-21Est. Completion: 2025-03-10
Enrollment target: 55 participants Locations- University of Southern California/Children's Hospital of Los Angeles/Huntington Hospital, Los Angeles, California, United States
- University of California San Francisco, San Francisco, California, United States
- Stanford University, Stanford, California, United States
- University of Colorado Denver, Aurora, Colorado, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Columbia University, New York, New York, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- University of Texas Health Science Center at Houston, Houston, Texas, United States
Other microbiome trials you might be interested in
Lower Urinary Tract Obstruction, Congenital
The purpose of this research is to determine the feasibility and safety of performing fetal operative cystoscopy for the…
Rochester, United StatesCompleted Mar 23, 2056
Autosomal Recessive Polycystic Kidney (ARPKD)
To evaluate the pharmacodynamics and safety of tolvaptan in pediatric subjects with ARPKD
Washington D.C., United StatesEst. completion Jul 31, 2028